Purpose: The aim was to evaluate whether the expression of cyclin D2 mRNA in human luteinized granulosa cells correlates with the clinical parameters of women undergoing in vitro fertilization-embryo transfer (IVF-ET
INTRODUCTION
One of the methods to estimate the ovarian function is to evaluate the ability of granulosa cells (GC) to proliferate and to synthesize estradiol (E 2 ) within the follicle. The number of granulosa cells that ultimately develop to a preovulatory follicle is determined by the balance between the rate of granulosa cell proliferation and that of cell death. Granulosa cell death via an apoptotic mechanism has been regarded as a negative regulator for follicle growth (1) (2) (3) . On the contrary, as a positive regulator, the insulinlike growth factors (IGF-I and IGF-II) promote ovarian follicular cell mitosis and differentiated function and can prevent granulosa cell apoptosis (4, 5) . Recent studies provide support for the involvement of the cell cycle regulatory molecules in the control of granulosa cell proliferation in response to hormones during follicular development (6) . Especially D-type cyclins (cyclin D1, D2, and D3) have been known as cell cycle activators in ovary. Among D-type cyclins, cyclin D2 is known as a rate-limiting positive cell cycle regulator that has a pivotal role in granulosa cell proliferation in mouse and rat ovary, whereas cyclin D1 and D3 are localized to theca cells (6) . Also, a critical role for cyclin D2 in the hormonedependent phase of follicular growth is illustrated by the ovarian follicles of mice null for cyclin D2 (7) . But, in humans, only one study was reported regarding the cyclin D2 expression in granulosa cell tumor (7) . So the expression pattern and role of cyclin D2 in human granulosa cells remain to be elucidated. In this study, we assessed the expression of cyclin D2 mRNA in human luteinized granulosa cells and tested whether or not cyclin D2 mRNA expression in human luteinized granulosa cells correlates with the clinical parameters of ovarian function in women undergoing in vitro fertilization-embryo transfer (IVF-ET) programs.
MATERIALS AND METHODS

Patients and Follicle Aspiration
Human luteinized granulosa cells were obtained from 20 women participating in an IVF program between January 1999 and April 1999 at Samsung Medical Center, Seoul, Korea. Eleven with infertility of unknown origin, four were associated with male factor infertility, two had a tubal factor, two had endometriosis, and one had an age factor (Table I ). The 
Granulosa cell Preparation
The follicular aspirates from large follicles were centrifuged for 10 min at 600 g and the cell pellet was resuspended with Ham's F-10 (Gibco-BRL, Grand Island, NY). The resuspended cells were layered in 3 ml 50% Percoll solution (Sigma, St. Louise, MO) and centrifuged for 5 min at 600 g to pellet the blood cells. Purified granulosa cells were aspirated from the interphase (1 to 2 ml) and washed twice with Ham's F-10 (8).
Hormone Assay
Serum levels of FSH, luteinizing hormone (LH), and E 2 on menstrual cycle day 3 were measured in a spontaneous menstrual cycle usually prior to the stimulated cycle. Serum levels of E 2 and P4 were determined at the day of hCG administration. Serum FSH, LH, and E 2 were measured with a commercially available radioimmunoassay kit (FSH-IRMA, LHsp-IRMA, E 2 -RIA-CT, Biosource, Belgium), and serum P4 level was measured by a commercially available double-antibody radioimmunoassay kit (Coat-ACount, Diagnostic Products Corporation, Los Angeles, CA). The sensitivities of the FSH, LH, E 2 , and P4 assay were 0.1 mIU/ml, 0.20 mIU/ml, 4.8 pg/ml, and 0.02 ng/ml, respectively. The intra-and interassay coefficients of variation of FSH, LH, E 2 , and P4 were Ͻ6%, Ͻ9%, Ͻ10%, and Ͻ15%, respectively. the elongation step was prolonged to 10 min at 74ЊC. The amount of template cDNA used in each reaction was normalized to the amount of GAPDH mRNA. Amplification of template cDNA was in the linear range for the number of PCR cycles and RT-PCR of GAPDH transcript was performed using the same amount of cDNA from each sample as a template. PCR products were visualized by electrophoresis on 1.5% (wt/vol) agarose gels.
Oligonucleotide Primers
Oligonucleotide PCR primers were selected with the assistance of a computer program (DNA STAR) designed to optimize GC content and melting temperature and to minimize hairpin and dimer formation. PCR primers were cyclin D2 for 5Ј-TACTT CAAGTGCGTGCAGAAGGAC-3Ј; cyclin D2 rev 5Ј-TCCCACACTTCCAGTTGCGATCAT-3Ј; GAPDH for 5Ј-ACCACAGTCCATGCCATCAC-3Ј; GAPDH rev 5Ј-TCCACCACCCTGTTGCT GTA-3Ј, which resulted in product of 489 bp and 452 bp, respectively.
Densitometry
Gel image was scanned with a gel documentation system (Gel Doc 1000, Bio-Rad Hercules, CA) and relative densities were analyzed using a multi-analyst fingerprinting program (version 1.1). The relative densities of the bands were expressed as arbitrary absorbance units per area.
Statistical Analysis
The correlation between cyclin D2 mRNA expression expressed by arbitrary unit and clinical parameters was tested by Spearman's correlation analysis. Differences of cyclin D2 mRNA expression between pregnant and nonpregnant group were analyzed by Wilcoxon's rank sum test. Statistical significance was given when P value was less than 0.05.
RESULTS
Four hundred eighty-nine base pair cyclin D2 and 452 bp GAPDH RT-PCR products were obtained in human luteinized granulosa cells. After the correction of cyclin D2 mRNA by GAPDH mRNA, the cyclin D2 mRNA expression was expressed by arbitrary unit. While cyclin D2 mRNA expression in lu-teinized granulosa cells showed negative correlation with age (R ϭ Ϫ0.60, P Ͻ 0.005) and total amount of gonadotropins used (R ϭ Ϫ0.45, P Ͻ 0.03), cyclin D2 mRNA expression showed positive correlation (R ϭ 0.55, P Ͻ 0.02) with serum E 2 levels at the day of hCG administration ( Fig. 1) . Although menstrual cycle day 3 serum FSH levels and the number of days of gonadotropin administration showed negative correlation with cyclin D2 mRNA expression (R ϭ Ϫ0.41 and R ϭ Ϫ0.37), there were no statistical significance (P ϭ 0.08 and P ϭ 0.11) (Fig. 2) . Other parameters (day 3 LH, E 2 ; P4 at the day of hCG) showed no correlation with cyclin D2 mRNA expression. Cyclin D2 mRNA expression of pregnant group was higher than that of nonpregnant group (P Ͻ 0.003) (Fig. 2) .
DISCUSSION
The cyclin D2 is one of critical governors of the cell cycle clock apparatus during the G1 phase of the mammalian cell cycle. Entry into the S phase is positively regulated by cyclin D2 (9-11). The cyclin D2 binds with cyclin-dependent kinase (cdk) 4 and 6, which allows phosphorylation by cdk-activating kinase (CAK), thereby forming an active complex. The cyclin-cdk complex phosphorylates cellular substrates, leading to activation of the E2F family of transcription factors. These result in the activation of numerous genes involved in DNA synthesis and ultimately enable cells to begin the transition from G1 to S phase. The targeted deletion of cyclin D2 gene indicates that it is essential for normal ovarian function. In mice null for cyclin D2, granulosa cell proliferation is impaired, the ovarian follicles remain small, and ovulation fails to occur (7) . This finding suggests that cyclin D2 is a rate-limiting activator of cell cycle progression and is essential for granulosa cell proliferation. Therefore, we postulated that cyclin D2 mRNA expression in granulosa cells reflects the follicle health especially in a dominant follicle that is destined to ovulate. In this study, we revealed that cyclin D2 mRNA is expressed in luteinized granulosa cells of all patients undergoing IVF-ET program for the first time. To our knowledge, there was only one study regarding the cyclin D2 expression in the human ovary in which ovarian granulosa cell tumors expressed very high levels of cyclin D2 mRNA compared with normal ovaries (7) . In rat, cyclin D2 mRNA is known to be down-regulated within 4 hr after hCG injection in granulosa cells of preovulatory follicles that are destined to ovulate (6) . Though we did not analyze the specific preovulatory follicles, the cyclin D2 mRNA in rat ovarian granulosa cells treated with PMSG showed a different pattern of expression after hCG injection. The decrease of cyclin D2 mRNA after hCG injection was not profound compared to before hCG injection (maximum 16% decrease 8 hr after hCG injection), and the cyclin D2 mRNA recovered thereafter up to the level of before-hCG injection (data not shown). This finding suggests that there may be no significant down-regulation of cyclin D2 mRNA expression of human luteinized granulosa cells in controlled ovarian hyperstimulation cycle at 35 hr after hCG injection. In human, 35 hr after hCG injection cyclin D2 mRNA was still detected in large follicles (Ն20 mm at the time of aspiration) that were considered as preovulatory follicles. Cyclin D2 mRNA expression showed negative correlation with age (R ϭ Ϫ0.60, P Ͻ 0.005) and amount of gonadotropins used (R ϭ Ϫ0.45, P Ͻ 0.03). Although there was no statistical significance, cyclin D2 mRNA expression also showed negative correlation with day 3 FSH (R ϭ Ϫ0.41, P ϭ 0.08) and the number of days of gonadotropin administration (R ϭ Ϫ0.37, P ϭ 0.11). Clinical parameters that showed negative correlation with cyclin D2 mRNA expression in this study are all known to be negatively associated with ovarian function. Also, cyclin D2 mRNA expression in the pregnant group was higher than that of the nonpregnant group (P Ͻ 0.003). These results indirectly suggest that cyclin D2 mRNA expression in human luteinized granulosa cells positively correlates with the clinical parameters of ovarian function.
In conclusion, analysis of cyclin D2 mRNA expression in human luteinized granulosa cells suggests that cyclin D2 mRNA expression in human luteinized granulosa cells positively correlate with the clinical parameters of ovarian function and may be a novel marker for the health of the human ovarian follicle. 
